« Back
Home /
BCI-215

BCI-215

Item no.	V12334-50mg
Manufacturer	InvivoChem LLC
CASRN	1245792-67-9
Amount	50 mg
Quantity options	10 mg 1 mg 500 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Description	InvivoChem Cat #:V12334CAS #:1245792-67-9Purity >=98% Description: BCI-215 is a novel, potent and selective dual specificity MAPK phosphatase (DUSP-MKP) inhibitor which has cytotoxicity for tumor cells but not normal cells. References: Kaltenmeier CT, Vollmer LL, Vernetti LA, Caprio L, Davis K, Korotchenko VN, Day BW, Tsang M, Hulkower KI, Lotze MT, Vogt A. A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity. J Pharmacol Exp Ther. 2017 Apr; 361(1):39-50. doi: 10.1124/jpet.116.239756. Epub 2017 Feb 2. PubMed PMID: 28154014; PubMed Central PMCID: PMC5363763.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50 mg

available

Delivery expected until 9/4/2025

Express Delivery: Save 16 days

Compare

Add to wishlist

Get an offer